Cooper Companies (NASDAQ:COO) Stock Breaks Below 50-Day Moving Average – Here’s Why

by · The Markets Daily

The Cooper Companies, Inc. (NASDAQ:COO – Get Free Report) shares crossed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $60.33 and traded as low as $59.01. Cooper Companies shares last traded at $59.55, with a volume of 7,892,171 shares.

More Cooper Companies News

Here are the key news stories impacting Cooper Companies this week:

  • Neutral Sentiment: Cooper Companies is expected to report fourth-quarter results soon. Analysts reportedly anticipate a single-digit decline in earnings per share, making the upcoming release important for confirming whether recent operational issues are temporary or more persistent. Cooper Companies quarterly earnings preview
  • Negative Sentiment: CEO Albert White has stepped down following pressure from activist investor Elliott Investment Management. The leadership transition adds uncertainty as Cooper works to address investor concerns about performance and strategy. Cooper Companies CEO steps down
  • Negative Sentiment: Investors continue to focus on the company’s disclosure that U.S. channel inventory was being reduced. The issue was cited as a major factor behind the sharp selloff following third-quarter results and raised concerns about near-term demand, sales timing and execution. Cooper Companies scrutinized over inventory reductions
  • Negative Sentiment: Several law firms, including Rosen Law Firm and Glancy Prongay Wolke & Rotter, are investigating potential securities claims related to allegations that Cooper Companies provided materially misleading business information. These announcements do not establish wrongdoing, but they increase reputational, legal and investor-sentiment risks. Cooper Companies securities investigation
  • Negative Sentiment: The combination of channel destocking, a CEO departure, projected earnings pressure and multiple securities-law investigations is weighing on confidence in COO, despite the company’s prior quarterly EPS beat and full-year 2026 guidance.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on COO. JPMorgan Chase & Co. dropped their price objective on shares of Cooper Companies from $71.00 to $58.00 and set a “neutral” rating for the company in a research note on Thursday, September 10th. Needham & Company LLC reduced their target price on Cooper Companies from $86.00 to $73.00 and set a “buy” rating on the stock in a research note on Thursday, September 10th. Stifel Nicolaus set a $70.00 target price on Cooper Companies and gave the company a “buy” rating in a report on Thursday, September 10th. Mizuho set a $75.00 price target on Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, September 10th. Finally, Wall Street Zen cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Saturday, September 12th. Four investment analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $68.60.

Check Out Our Latest Analysis on Cooper Companies

Cooper Companies Price Performance

The company has a 50-day moving average of $60.33 and a two-hundred day moving average of $69.09. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 0.73. The stock has a market capitalization of $11.32 billion, a PE ratio of 20.32, a P/E/G ratio of 2.42 and a beta of 0.83.

Cooper Companies (NASDAQ:COO – Get Free Report) last posted its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.12 by $0.03. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%. The company had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same quarter in the previous year, the business earned $0.49 EPS. The firm’s revenue was up .5% on a year-over-year basis. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 4.53 EPS for the current fiscal year.

Cooper Companies announced that its board has initiated a share repurchase plan on Wednesday, September 9th that authorizes the company to repurchase $3 billion in shares. This repurchase authorization authorizes the medical device company to buy up to 22.7% of its shares through open market purchases. Stock repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

Insider Buying and Selling

In related news, Director Walter M. Rosebrough, Jr. purchased 7,000 shares of the firm’s stock in a transaction on Friday, September 11th. The shares were bought at an average price of $54.11 per share, for a total transaction of $378,770.00. Following the acquisition, the director directly owned 17,000 shares in the company, valued at $919,870. This trade represents a 70.00% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this link. Also, Director Lawrence Kurzius acquired 10,000 shares of the stock in a transaction dated Monday, September 14th. The shares were bought at an average cost of $53.91 per share, with a total value of $539,100.00. Following the completion of the purchase, the director directly owned 21,099 shares in the company, valued at approximately $1,137,447.09. This trade represents a 90.10% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last quarter, insiders purchased 34,701 shares of company stock valued at $1,880,039. Insiders own 2.08% of the company’s stock.

Institutional Trading of Cooper Companies

Institutional investors and hedge funds have recently made changes to their positions in the company. Rakuten Investment Management Inc. purchased a new position in Cooper Companies in the 3rd quarter valued at about $1,982,000. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Cooper Companies during the third quarter valued at about $3,096,000. ProShare Advisors LLC grew its stake in shares of Cooper Companies by 2.2% during the third quarter. ProShare Advisors LLC now owns 32,067 shares of the medical device company’s stock valued at $1,813,000 after acquiring an additional 692 shares in the last quarter. Vise Technologies Inc. increased its position in shares of Cooper Companies by 23.5% during the third quarter. Vise Technologies Inc. now owns 6,093 shares of the medical device company’s stock worth $344,000 after acquiring an additional 1,158 shares during the last quarter. Finally, International Assets Investment Management LLC increased its position in shares of Cooper Companies by 506.0% during the third quarter. International Assets Investment Management LLC now owns 23,166 shares of the medical device company’s stock worth $1,310,000 after acquiring an additional 19,343 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

About Cooper Companies

(Get Free Report)

CooperCompanies is a global medical device company that develops, manufactures and markets products for vision care and women’s health. The company operates through two primary business segments: CooperVision and CooperSurgical.

CooperVision provides contact lenses and related technologies, including products designed for myopia management, astigmatism, presbyopia and other vision-correction needs. Its portfolio includes daily disposable, reusable and specialty contact lenses sold through eye-care professionals and distributors.

CooperSurgical develops products and services for fertility and women’s health.

Featured Articles